Skip to main content

Closed

IBRX: ImmunityBio, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

50thpctl

Volume

0.73×avg

Market Cap

7.51BUSD

P/E Ratio

-8.4TTM

Div Yield

-ann

ImmunityBio, Inc.

IBRXNASDAQ Global Select·USD·Closed

ImmunityBio, Inc.

IBRXNASDAQ·USD·Closed

$7.17

−3.76%

$7.17

−$0.28 (3.76%)

52W Range

50thpctl

Volume

0.73×avg

Mkt Cap

7.51BUSD

P/E

-8.4TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings